Cargando…

Genetic variants of genes in the Notch signaling pathway predict overall survival of non-small cell lung cancer patients in the PLCO study

The Notch signaling pathway has been shown to have biological significance and therapeutic application in non-small cell lung cancer (NSCLC). We hypothesize that genetic variants of genes in the Notch signaling pathway are associated with overall survival (OS) of NSCLC patients. To test this hypothe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Yinghui, Wang, Yanru, Liu, Hongliang, Kang, Xiaozheng, Li, Wei, Wei, Qingyi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5308685/ https://www.ncbi.nlm.nih.gov/pubmed/27557513 http://dx.doi.org/10.18632/oncotarget.11436

Ejemplares similares

Variants in Notch signalling pathway genes, PSEN1 and MAML2, predict overall survival in Chinese patients with epithelial ovarian cancer
por: Xu, Yuan, et al.
Publicado: (2018)

Genetic variants of PDGF signaling pathway genes predict cutaneous melanoma survival
por: Li, Hong, et al.
Publicado: (2017)

Novel genetic variants in genes of the Fc gamma receptor-mediated phagocytosis pathway predict non-small cell lung cancer survival
por: Qian, Danwen, et al.
Publicado: (2020)

Genetic Variants of CLEC4E and BIRC3 in Damage-Associated Molecular Patterns-Related Pathway Genes Predict Non-Small Cell Lung Cancer Survival
por: Liu, Lihua, et al.
Publicado: (2021)

Detection method has independent prognostic significance in the PLCO lung screening trial
por: Long, James P., et al.
Publicado: (2023)

Genetic variants in Fanconi Anemia Pathway Genes BRCA2 and FANCA Predict Melanoma Survival
por: Yin, Jieyun, et al.
Publicado: (2014)

Association of genetic variants of TMEM135 and PEX5 in the peroxisome pathway with cutaneous melanoma-specific survival
por: Wang, Haijiao, et al.
Publicado: (2021)

Seropositivity for Helicobacter pylori and hepatobiliary cancers in the PLCO study
por: Makkar, Rishi, et al.
Publicado: (2020)

Associations between genetic variants in mRNA splicing-related genes and risk of lung cancer: a pathway-based analysis from published GWASs
por: Pan, Yongchu, et al.
Publicado: (2017)

Novel Genetic Variants of ALG6 and GALNTL4 of the Glycosylation Pathway Predict Cutaneous Melanoma-Specific Survival
por: Zhou, Bingrong, et al.
Publicado: (2020)

Genetic variants of SDCCAG8 and MAGI2 in mitosis‐related pathway genes are independent predictors of cutaneous melanoma‐specific survival
por: He, Yuanmin, et al.
Publicado: (2021)

Coffee, tea, caffeine intake, and the risk of cancer in the PLCO cohort
por: Hashibe, Mia, et al.
Publicado: (2015)

Recalibrating Risk Prediction Models by Synthesizing Data Sources: Adapting the Lung Cancer PLCO Model for Taiwan
por: Chien, Li-Hsin, et al.
Publicado: (2022)

Integrative Genomic Analysis Reveals Extended Germline Homozygosity with Lung Cancer Risk in the PLCO Cohort
por: Orloff, Mohammed S., et al.
Publicado: (2012)

Dairy Product Consumption and Bladder Cancer Risk in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cohort
por: Xu, Xin
Publicado: (2020)

The Significance of Notch1 Compared with Notch3 in High Metastasis and Poor Overall Survival in Hepatocellular Carcinoma
por: Zhou, Liang, et al.
Publicado: (2013)

Osteopontin genetic variants are associated with overall survival in advanced non-small-cell lung cancer patients and bone metastasis
por: Chen, Yunzhen, et al.
Publicado: (2013)

Genetic Variants of CLPP and M1AP Are Associated With Risk of Non-Small Cell Lung Cancer
por: Li, Xianghan, et al.
Publicado: (2021)

Genetic variants in ERCC1 and XPC predict survival outcome of non-small cell lung cancer patients treated with platinum-based therapy
por: Zhang, Ruoxin, et al.
Publicado: (2017)

Body mass index (BMI) trajectories and risk of colorectal cancer in the PLCO cohort
por: Zheng, Rui, et al.
Publicado: (2018)

Prediction of future risk of any and higher-grade prostate cancer based on the PLCO and SELECT trials
por: Gelfond, Jonathan A., et al.
Publicado: (2022)

Associations between genetic variants of KIF5B, FMN1, and MGAT3 in the cadherin pathway and pancreatic cancer risk
por: Zhao, Lingling, et al.
Publicado: (2020)

OWL: an optimized and independently validated machine learning prediction model for lung cancer screening based on the UK Biobank, PLCO, and NLST populations
por: Pan, Zoucheng, et al.
Publicado: (2023)

Body mass index and mortality among blacks and whites in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial
por: Xiao, Qian, et al.
Publicado: (2013)

Evaluation of the Lung Cancer Risks at Which to Screen Ever- and Never-Smokers: Screening Rules Applied to the PLCO and NLST Cohorts
por: Tammemägi, Martin C., et al.
Publicado: (2014)

Aspirin but not ibuprofen use is associated with reduced risk of prostate cancer: a PLCO Study
por: Shebl, F M, et al.
Publicado: (2012)

Weight Change and Incident Distal Colorectal Adenoma Risk in the PLCO Cancer Screening Trial
por: He, Shisi, et al.
Publicado: (2022)

TXNIP interaction with the Her-1/2 pathway contributes to overall survival in breast cancer
por: Nie, Weiwei, et al.
Publicado: (2014)

Correction: Evaluation of the Lung Cancer Risks at Which to Screen Ever- and Never-Smokers: Screening Rules Applied to the PLCO and NLST Cohorts
Publicado: (2015)

The impact of folate intake on the risk of head and neck cancer in the prostate, lung, colorectal, and ovarian cancer screening trial (PLCO) cohort
por: Kawakita, Daisuke, et al.
Publicado: (2018)

White blood cell DNA methylation and risk of breast cancer in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial (PLCO)
por: Sturgeon, Susan R., et al.
Publicado: (2017)

Association between soft drink consumption types and risk of lung cancer and all-cancer: A prospective study of PLCO data
por: You, Dongfang, et al.
Publicado: (2022)

Analysis of lung cancer risk model (PLCO(M2012) and LLP(v2)) performance in a community-based lung cancer screening programme
por: Lebrett, Mikey B, et al.
Publicado: (2020)

Three novel genetic variants in NRF2 signaling pathway genes are associated with pancreatic cancer risk
por: Yang, Wenjun, et al.
Publicado: (2019)

Gut Microbiome–Dependent Metabolic Pathways and Risk of Lethal Prostate Cancer: Prospective Analysis of a PLCO Cancer Screening Trial Cohort
por: Reichard, Chad A., et al.
Publicado: (2022)

A biomarker basing on radiomics for the prediction of overall survival in non–small cell lung cancer patients
por: He, Bo, et al.
Publicado: (2018)

Prospective study of the relationship between coffee and tea with colorectal cancer risk: The PLCO Cancer Screening Trial
por: Dominianni, C, et al.
Publicado: (2013)

GWAS Explorer: an open-source tool to explore, visualize, and access GWAS summary statistics in the PLCO Atlas
por: Machiela, Mitchell J., et al.
Publicado: (2023)

Genetic Variations in the Transforming Growth Factor-β1 Pathway May Improve Predictive Power for Overall Survival in Non-small Cell Lung Cancer
por: Zhang, Hong, et al.
Publicado: (2021)

Non-small-cell lung carcinoma: role of the Notch signaling pathway
por: Barse, Levi, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_k650sj7vuhi1qf6ijt9oa84aem